NCT01041690View on ClinicalTrials.gov

Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Proliferative Diabetic Retinopathy
Interventions
DRUG

Bevacizumab

Trial Locations (1)

11221

Department Of Ophthalmology, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT01041690 - Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease | Biotech Hunter | Biotech Hunter